Efficacy and Safety of Org 25969 Administered After Zemuron® (MK-8616-042)

Clinical trial NCT03519867 · COMPLETED

Trial details

NCT number: NCT03519867
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuromuscular Blockade

Start date: 2004-08-01
Primary completion: 2005-05-26
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.